In April the world's first Marijuana Exchange Traded Fund, Horizon Medical Marijuana Life Sciences ETF (TSE:HMMJ) hit the public markets. The ETF went public at $10 per share and popped during its first few days of trading.
When HMMJ hit the public markets, investors were craving exposure to marijuana stocks as new laws and regulations have helped push marijuana into the mainstream spotlight. Some U.S. states and parts of Canada have decriminalized the drug while it has spread in popularity and acceptance for its medical use.
HMMJ has traded as high as $23 per share since going public, but currently, it is below its Initial Public Offering price, trading at $9.36 per share. So what is happening and is it worth investing in the industry today? Continue reading "Should You Be Investing In Marijuana" →
Analysis originally distributed on May 10, 2017 By: Michael Vodicka of Cannabis Stock Trades
If you like getting a good deal then once again the time has come to take a look at cannabis stocks.
The cannabis sector has fallen into a bear market. A bear market happens when a stock falls 20% or more from its 52-week high.
After posting massive gains in 2016 and early 2017 – the MJIC Index North American Cannabis Index is down 25% from its 52-week high. Take a look.
I don’t see any fundamental reason for the pullback. As always there has been plenty of good news coming out of the cannabis industry. Continue reading "First Ever Cannabis ETF: Friend or Foe?" →
Analysis originally distributed on April 26, 2017 By: Michael Vodicka of Cannabis Stock Trades
Israel has long been a powerhouse in medical innovation.
The tiny country of 8.5 million has made some of the most important contributions to the global medical field in the last 50 years.
Today, Israel is unleashing its innovative medical industry on the cannabis industry.
According to a report from Reuters, there are more than 120 clinical cannabis trials in Israel at the beginning of 2017, more than any other country.
Foreign countries and firms are eager to license Israel cannabis medical patents. In the last year outside countries and companies have invested $100 million to license Israeli medical cannabis patents.
That number is expected to grow to more than $1 billion in the next two years - an increase of 1,000%.
Israel is winning in the global cannabis industry for two reasons. Continue reading "This Little-Known Israeli Biotech Is Up 468% In 2017" →
Analysis originally distributed on April 24, 2017 By: Michael Vodicka of Cannabis Stock Trades
Cannabis legalization is happening all across the globe.
This week, that global footprint is taking us to a country located at the far reaches of the Amazon Rain Forest, tucked into the southeastern coast of South America.
More than 2,000 miles south of the equator, a tiny country of 3.4 million citizens is about to become the first in South America to sell recreational cannabis.
And an up and coming company with one of the few permits to sell cannabis is in position to cash in.
Let me explain…. Continue reading "Profit From South America's First Cannabis Stock" →
Analysis originally distributed on April 12, 2017 By: Michael Vodicka of Cannabis Stock Trades
Studies have found that legalizing cannabis has an overwhelmingly positive effect on society.
It takes the illegal drug trade out of the hands of foreign cartels and puts it into the hands of tax-paying, law-abiding businesses.
It reduces crime.
And it helps generate additional tax revenue. Continue reading "The Cannabis Stock That Every Police Department Needs" →